You Are Here    News

New WHO algorithm to prevent TB deaths in very ill people with HIV
by Theo Smart, 2016-08-23 08:40
The World Health Organization (WHO) has released a new diagnostic algorithm in order to reduce the likelihood of ‘seriously ill’ people with HIV dying of undiagnosed and untreated tuberculosis (TB). “Despite being preventable and curable TB is still the leading cause of morbidity and mortality, even in the era of antiretroviral therapy (ART) going

German medicines watchdog rejects ‘new tenofovir’ pill
by Gus Cairns, 2016-08-22 10:30
The German health technology assessment agency IQWiG has announced that it finds no advantage in Descovy, a combination pill containing a new version of the HIV drug tenofovir, over its alternative, Truvada, which is the most widely-used HIV medicine. A press release say that it will not be recommending the provision of

How can clinical services engage men who have sex with men in Africa?
by Roger Pebody, 2016-08-19 10:40
Men who have sex with men living in African countries have an extremely high burden of HIV, Stefan Baral of Johns Hopkins University reminded delegates at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa last month. Across the region, the average prevalence of HIV in men who have sex with men (MSM) is

Poor kidney function associated with increased cardiovascular risk for people with HIV
by Michael Carter, 2016-08-18 11:00
Renal impairment is associated with an increased risk of cardiovascular disease (CVD) in HIV-positive individuals, according to data from a large observational cohort study published in the online edition of the Journal of Infectious Diseases. Within five years of follow-up, over a fifth of patients with severely impaired kidney function developed cardiovascular disease compared to

Most contraceptives not linked to HIV infection, but Depo-Provera may raise risk
by Liz Highleyman, 2016-08-17 08:40
Birth control pills and some types of injectable and implanted contraceptives were not associated with an increased risk of HIV acquisition in an updated meta-analysis that included several recent studies, researchers reported in the August 5 online edition of AIDS. However, evidence continues to suggest that use of depot medroxyprogesterone acetate (DMPA or Depo-Provera) raises